{"id":"https://openalex.org/W4387721986","doi":"https://doi.org/10.1016/j.biocel.2023.106477","title":"DNA mismatch repair deficient cancer \u2013 Emerging biomarkers of resistance to immune checkpoint inhibition","display_name":"DNA mismatch repair deficient cancer \u2013 Emerging biomarkers of resistance to immune checkpoint inhibition","alternate_titles":[],"publication_year":2023,"publication_date":"2023-10-17","ids":{"openalex":"https://openalex.org/W4387721986","doi":"https://doi.org/10.1016/j.biocel.2023.106477","pmid":"https://pubmed.ncbi.nlm.nih.gov/37862741"},"language":"en","primary_location":{"id":"doi:10.1016/j.biocel.2023.106477","doi":"https://doi.org/10.1016/j.biocel.2023.106477","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biocel.2023.106477","pdf_url":null,"source":{"id":"https://openalex.org/S183320690","display_name":"The International Journal of Biochemistry & Cell Biology","issn_l":"1357-2725","issn":["1357-2725","1878-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Biochemistry &amp; Cell Biology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4387721986"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.biocel.2023.106477","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026985089","display_name":"Kirsten Brooksbank","orcid":"https://orcid.org/0000-0001-6129-2113","observed_orcids":["https://orcid.org/0000-0001-6129-2113"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kirsten Brooksbank","raw_affiliation_strings":["Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033773451","display_name":"Sarah A. Martin","orcid":"https://orcid.org/0000-0003-3321-6601","observed_orcids":["https://orcid.org/0000-0003-3321-6601"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Sarah A. Martin","raw_affiliation_strings":["Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: sarah.martin@qmul.ac.uk","Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: sarah.martin@qmul.ac.uk","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5033773451"],"corresponding_institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":0.3549,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.37415929,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"164","issue":null,"first_page":"106477","last_page":"106477"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11369","display_name":"Genetic factors in colorectal cancer","score":0.00989999994635582,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mismatch-repair-deficiency","display_name":"mismatch repair deficiency","score":0.996999979019165},{"id":"https://openalex.org/keywords/microsatellite-instability","display_name":"microsatellite instability","score":0.9419999718666077},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9319999814033508},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.7829999923706055},{"id":"https://openalex.org/keywords/resistance-mechanisms","display_name":"resistance mechanisms","score":0.7120000123977661},{"id":"https://openalex.org/keywords/resistance-biomarkers","display_name":"resistance biomarkers","score":0.7369999885559082},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.625},{"id":"https://openalex.org/keywords/patient-stratification","display_name":"patient stratification","score":0.609000027179718},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C60748783","wikidata":"https://www.wikidata.org/wiki/Q2984243","display_name":"DNA mismatch repair","level":4,"score":0.8653923869132996},{"id":"https://openalex.org/C2779767149","wikidata":"https://www.wikidata.org/wiki/Q488212","display_name":"Microsatellite instability","level":5,"score":0.8637880682945251},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7379043698310852},{"id":"https://openalex.org/C119054055","wikidata":"https://www.wikidata.org/wiki/Q1576681","display_name":"Indel","level":5,"score":0.7077155113220215},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.6979163885116577},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.6857895851135254},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5159772038459778},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4818609654903412},{"id":"https://openalex.org/C54086632","wikidata":"https://www.wikidata.org/wiki/Q5512671","display_name":"G2-M DNA damage checkpoint","level":5,"score":0.44926121830940247},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.43545228242874146},{"id":"https://openalex.org/C187206112","wikidata":"https://www.wikidata.org/wiki/Q3113091","display_name":"Base excision repair","level":4,"score":0.4287444055080414},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.42393097281455994},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40786558389663696},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.3866897225379944},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34826648235321045},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.25958049297332764},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.25217771530151367},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.22497999668121338},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.21007058024406433},{"id":"https://openalex.org/C61320498","wikidata":"https://www.wikidata.org/wiki/Q265193","display_name":"Microsatellite","level":4,"score":0.165860116481781},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11133050918579102},{"id":"https://openalex.org/C153209595","wikidata":"https://www.wikidata.org/wiki/Q501128","display_name":"Single-nucleotide polymorphism","level":4,"score":0.09987130761146545},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.09075748920440674},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.053690701723098755},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009386","descriptor_name":"Neoplastic Syndromes, Hereditary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D053842","descriptor_name":"Microsatellite Instability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053843","descriptor_name":"DNA Mismatch Repair","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.biocel.2023.106477","doi":"https://doi.org/10.1016/j.biocel.2023.106477","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biocel.2023.106477","pdf_url":null,"source":{"id":"https://openalex.org/S183320690","display_name":"The International Journal of Biochemistry & Cell Biology","issn_l":"1357-2725","issn":["1357-2725","1878-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Biochemistry &amp; Cell Biology","raw_type":"journal-article"},{"id":"pmid:37862741","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37862741","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of biochemistry & cell biology","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.1016/j.biocel.2023.106477","doi":"https://doi.org/10.1016/j.biocel.2023.106477","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biocel.2023.106477","pdf_url":null,"source":{"id":"https://openalex.org/S183320690","display_name":"The International Journal of Biochemistry & Cell Biology","issn_l":"1357-2725","issn":["1357-2725","1878-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Biochemistry &amp; Cell Biology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6267139746","display_name":null,"funder_award_id":"G-002359","funder_id":"https://openalex.org/F4320315977","funder_display_name":"Barts Charity"},{"id":"https://openalex.org/G8435743392","display_name":null,"funder_award_id":"S_4227","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G8557033727","display_name":null,"funder_award_id":"MGU0403","funder_id":"https://openalex.org/F4320315977","funder_display_name":"Barts Charity"}],"funders":[{"id":"https://openalex.org/F4320315977","display_name":"Barts Charity","ror":"https://ror.org/0513pp416"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1559117436","https://openalex.org/W1940241680","https://openalex.org/W1984642649","https://openalex.org/W2033632793","https://openalex.org/W2049553585","https://openalex.org/W2072343463","https://openalex.org/W2089484373","https://openalex.org/W2171190137","https://openalex.org/W2465860350","https://openalex.org/W2529308344","https://openalex.org/W2557336488","https://openalex.org/W2587832717","https://openalex.org/W2725858612","https://openalex.org/W2737084095","https://openalex.org/W2790812276","https://openalex.org/W2794560540","https://openalex.org/W2794612508","https://openalex.org/W2918954087","https://openalex.org/W2921371587","https://openalex.org/W2942698526","https://openalex.org/W2973095158","https://openalex.org/W2984359187","https://openalex.org/W2992921938","https://openalex.org/W3015035400","https://openalex.org/W3018059490","https://openalex.org/W3026325163","https://openalex.org/W3107694363","https://openalex.org/W3110528877","https://openalex.org/W3111020808","https://openalex.org/W3112754342","https://openalex.org/W3118655301","https://openalex.org/W3193419934","https://openalex.org/W3206775306","https://openalex.org/W3211279502","https://openalex.org/W4210362744","https://openalex.org/W4281732693","https://openalex.org/W4295817629","https://openalex.org/W4318753937","https://openalex.org/W4321763927","https://openalex.org/W4367318263","https://openalex.org/W4376135116","https://openalex.org/W4383695060","https://openalex.org/W4386741066","https://openalex.org/W6852412654"],"related_works":["https://openalex.org/W2467321712","https://openalex.org/W2947159010","https://openalex.org/W2215953110","https://openalex.org/W4242463343","https://openalex.org/W4412156049","https://openalex.org/W2166316862","https://openalex.org/W1541049358","https://openalex.org/W2733051925","https://openalex.org/W2905299787","https://openalex.org/W2622499649"],"abstract_inverted_index":{"The":[0],"DNA":[1,38],"mismatch":[2,65,104,135],"repair":[3,12,23,66,105,136],"pathway":[4],"is":[5,114,147],"involved":[6],"in":[7,19,26,34,57,89,120,150,181],"the":[8,20,45,81,121,163,182],"identification,":[9],"excision,":[10],"and":[11,16,32,112],"of":[13,29,37,74,103,118,128,145,153,166,173],"base-base":[14],"mismatches":[15],"indel":[17],"loops":[18],"genome.":[21],"Mismatch":[22],"deficiency":[24],"occurs":[25],"approximately":[27],"20%":[28],"all":[30,58],"cancers":[31,138],"results":[33],"a":[35,84,90,115,151],"type":[36],"damage":[39],"called":[40],"microsatellite":[41,71],"instability.":[42],"In":[43,157],"2017,":[44],"immune":[46,131,178],"checkpoint":[47,132,179],"inhibitor,":[48],"Pembrolizumab,":[49],"an":[50],"anti-PD-1":[51],"therapy,":[52],"was":[53,80],"approved":[54,88],"for":[55,134,175],"use":[56],"unresectable":[59],"or":[60,68],"metastatic":[61],"tumours":[62,107],"that":[63,99],"were":[64],"deficient":[67,106,137],"had":[69,86],"high":[70],"instability":[72],"regardless":[73],"tissue":[75],"origin.":[76],"This":[77],"landmark":[78],"approval":[79],"first":[82],"time":[83],"drug":[85],"been":[87,140],"site":[91],"agnostic":[92],"way,":[93],"but":[94,142],"accumulating":[95],"data":[96],"has":[97],"revealed":[98],"up":[100],"to":[101,110,130],"50%":[102],"are":[108],"refractory":[109],"treatment":[111,176],"there":[113],"huge":[116],"amount":[117],"variability":[119],"therapeutic":[122],"benefit":[123],"amongst":[124],"responders.":[125],"Several":[126],"mechanisms":[127,165],"resistance":[129,149,167],"blockade":[133],"have":[139],"identified":[141],"our":[143],"understanding":[144],"what":[146],"driving":[148],"proportion":[152],"patients":[154,174],"remains":[155],"lacking.":[156],"this":[158],"review":[159],"article,":[160],"we":[161],"discuss":[162],"emerging":[164],"which":[168],"may":[169],"enable":[170],"optimal":[171],"stratification":[172],"with":[177],"inhibitors":[180],"future.":[183]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4387721986","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2023-10-18T00:00:00"}
